Share on LinkedInShare on LinkedIn

ARTICLE · 16 JULY 2018

Scientist Settles SEC Insider Trading Charges

Hogan Lovells Cadwalader
Hogan Lovells Cadwalader
Contributor
Hogan Lovells Cadwalader

Hogan Lovells Cadwalader

Hogan Lovells Cadwalader is a global law firm trusted by clients to deliver on complex, high-stakes...

View firm profile
Explore more from Hogan Lovells Cadwalader

A former scientist at a California-based biotech company agreed to settle SEC insider trading charges.

United StatesCorporate/Commercial Law

A former scientist at a California-based biotech company agreed to settle SEC insider trading charges.

According to an SEC Complaint filed in the U.S. District Court for the Northern District of California, the Defendant was a scientist who worked on the development of a genetic sequencing platform. The SEC alleges that the Defendant made numerous profitable trades in advance of announcements touting (i) the achievement of certain scientific product milestones and (ii) the product launch. The SEC alleges that the Defendant's trading activity occurred during "blackout periods," in which his company prohibited employees from trading in its stock. The SEC also alleges that the Defendant shared material nonpublic information with a relative, with the intention that the relative benefit from trading on the information. The Defendant allegedly generated over $40,000 through trading on this non-public information.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from